Ventricular Assist Device
0
Pipeline Programs
3
Companies
3
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
3 companies ranked by most advanced pipeline stage
Bryan CorporationOH - Cincinnati
1 programMulti-Site Feasibility Testing of the Ventricular Assist Device Anticipatory Guidance ToolN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Bryan CorporationMulti-Site Feasibility Testing of the Ventricular Assist Device Anticipatory Guidance Tool
Supira MedicalSupira System
Rhine PharmaSelf-management curriculum
Clinical Trials (3)
Total enrollment: 150 patients across 3 trials
NCT06823583Bryan CorporationMulti-Site Feasibility Testing of the Ventricular Assist Device Anticipatory Guidance Tool
Multi-Site Feasibility Testing of the Ventricular Assist Device Anticipatory Guidance Tool
Start: Aug 2025Est. completion: Dec 202610 patients
N/ARecruiting
A Safety and Effectiveness Study of the Supira System in Patients Undergoing HRPCI - CE Study
Start: Jan 2024Est. completion: Sep 20260
N/AWithdrawn
Improved Self-management for Patients on Ventricular Assist Device (VAD) Support - Phase 3
Start: Sep 2020Est. completion: Jan 2023140 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 150 patients
3 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.